SCHEMBL17968618

SCHEMBL17968618

c1ccc(-c2ccccc2Nc2ccccc2-c2ccc3sc4ccccc4c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP3 P05413 1/20 0.43
▸ FABP4 P15090 1/20 0.43
▸ FABP5 Q01469 1/20 0.43
▸ GPR3 P46089 1/20 0.42
▸ CDC25B P30305 1/20 0.42
▸ ALOX5 P09917 1/20 0.41
▸ F9 P00740 1/20 0.38
▸ PIM3 Q86V86 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ PTGIR P43119 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MYC P01106 1/20 0.36
▸ MAX P61244 1/20 0.36
▸ PTPN7 P35236 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN12 Q05209 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25502796 0.90 PTGIR (0.39) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL27384048 0.90 MAP3K8 (0.41) GPR3CDC25BALOX5PIM3CYP1A2
SCHEMBL23168466 0.90 MAPT (0.43) GPR3CDC25BALOX5PIM3CYP1A2
SCHEMBL18333651 0.89 MAP3K8 (0.40) GPR3CDC25BALOX5PIM3CYP1A2
SCHEMBL18294162 0.89 PIM3 (0.40) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL17779549 0.88 SIRT2 (0.40) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL18216689 0.87 PTGIR (0.48) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL29514897 0.87 PTGIR (0.48) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL29892194 0.86 ALOX5 (0.36) FABP3FABP4FABP5GPR3CDC25B
SCHEMBL24156127 0.86 ALOX5 (0.41) GPR3CDC25BALOX5PIM3PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871212-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-01-16 — — US disclosed
US-9871212-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-01-16 — — US disclosed
US-20160233423-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-08-11 — — US disclosed
US-20160233423-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233423-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES CCND2, OXSR1, C1R FABP3 4195/4885FABP4 3165/4885FABP5 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback